Orthopedic Device Firms Lobby Hard On COVID-19 Relief And Reimbursements, Among Other Issues
Firms including Depuy Synthes, Medtronic Inc., and Zimmer Biomet Holdings Inc., spent thousands of dollars lobbying Congress last winter.
You may also be interested in...
A new US HHS report highlights ways the agency and coronavirus relief legislation are seeking to prevent high-cost surprise billing of patients with the novel coronavirus.
The largest medtech industry group has asked the Office of the US Trade Representative to waive tariffs on more medical devices imported from China as the US fights the COVID-19 crisis. AdvaMed wants an indefinite waiver, or at least one that extends a year beyond when the WHO declares an end to the pandemic.
With US House passage of a $484bn coronavirus relief package late on 23 April, Congress has allocated another substantial chunk of funding to support nationwide COVID-19 testing. President Trump signed the bill midday on 24 April.